{"name":"Noile-Immune Biotech, Inc","slug":"noile-immune-biotech-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPeWFEVUhTNlQ4T0xqUTBPekhzV21vdVhrTUFTdmoySXJ6eTJQZVlBc2I0ckE4aG53Y3hIY1FrREhmR1ZvRHZveEFYM1g2a1lMMTY5NWlrY1lxYXlOSm9hVlNOUE5kQmxNSmNZWHU0ZHNqZUtzUFBicDVhX0xFWExGYVVSVnU?oc=5","date":"2025-10-02","type":"trial","source":"Oncology Pipeline","summary":"Takeda’s cancer prospects dim further | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Takeda’s cancer prospects dim further | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5EbEZXNmloNFctTWkxNTk5ZXkzWF9FWm5sZVFhVzRWTmtVUFhBT3dySkV2eEFzZDUtLXNwZm11djdaQXdyR2RSZWdzMVF3dV9tWDduT1J3OV9hRmZTVUNONVNvNlU4UlRUX3EtSWg1MGxQT2xqRzNQMG4zbw?oc=5","date":"2024-02-27","type":"pipeline","source":"Labiotech.eu","summary":"Japan’s ten hottest biotech companies in healthcare - Labiotech.eu","headline":"Japan’s ten hottest biotech companies in healthcare","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-02-22","type":"regulatory","source":"Express Pharma","summary":"Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies: GlobalData - Express Pharma","headline":"Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies: GlobalData","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9mUjl0T2g4d3o5ZzFPLWpWNlFDRnVIaWozT1ozRnlWa3o2cUoyS3pobXNGSFM5bkZuNWlQV3NITFQ4bVVZR3F4NllxcXhRaVNqWnRVN2pRaHZ0UlpIQm9EanRLdDJVVEh2c05DZE1KNkc?oc=5","date":"2020-09-17","type":"pipeline","source":"Labiotech.eu","summary":"The Top 10 Biotech Companies Brewing at Oxford - Labiotech.eu","headline":"The Top 10 Biotech Companies Brewing at Oxford","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPenVUQTlqMy1VcUlIOUNiQ2FvVHQ0OHh5cmVMaVBBNnZsRHB5UC1pWFN0RDUzYmNGN1Z3TDNTYWFja0s2ZjBYZFhFT19JczNjdHY1cV9UWFZaaWoyTTJ3LTd0azE1Z0swU0IxQjBNODJtUHcyQWYwZzh6ZHd2NXpqQWl2WG8tbjRreTJCQ3BMWDVsRTRiWUpHby0ydF9VdGVUVUp2czdfNGN3ZTZjc0tvOFlRX0F1NzgzSnkzUUszelY1Z01ubEZjamUxX0xWT0JFaXYwOVMyclhVcXl1dV9SQ2ZRY2FlVkp2RHBIbmNB?oc=5","date":"2015-12-11","type":"patent","source":"Asian Scientist Magazine","summary":"Teva & Takeda Enter Joint Venture For Generics In Japan - Asian Scientist Magazine","headline":"Teva & Takeda Enter Joint Venture For Generics In Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPMG13bE15TFNiOVU3SXg0TUJRZjd0YWZRbTJsOHBYNk1icld3OE5NRjBFY2JVM0JoaEk4TzR6VkVCMzVSd1JLTHd5eUJxRGppbDNDRGxHWFI1YXlhVzFOM1lBeU5CelUyRkFyRkpkcURZTEZfbFNyWlJrWjFmUTdQMjZydEFLZ3FrSTlIVl9SRm81UVhIdGFjclNB?oc=5","date":"2014-01-03","type":"pipeline","source":"Asian Scientist Magazine","summary":"Takeda Submits New Drug Application For Fomepizole - Asian Scientist Magazine","headline":"Takeda Submits New Drug Application For Fomepizole","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPLXNBTXZjc1FKcm9mQTZTUTlnQmFxd3RQNVhobkxnc0pIOVNXT3B6aC1qaHZaeXpIcTcxSVpiN3k1WkJhOXR4WklWdkVOZGZyMmwwZWhfSjNUOHBfMzFCdWdXYVJhYWlXbDJDREthVGpJTmRPNlZROEpBaU55aGV4bVA4bmgxclQ4VFJkRGhXYjhYUHRxOHFlWFM1RHdhMy13YnF3SzR1VnJ0cXFyXzZv?oc=5","date":"2013-08-06","type":"pipeline","source":"Asian Scientist Magazine","summary":"Oral Rheumatoid Arthritis Treatment XELJANZ® Launched In Japan - Asian Scientist Magazine","headline":"Oral Rheumatoid Arthritis Treatment XELJANZ® Launched In Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOWFh6RGxxS1BIQVR2aVBZazdJMThTZ2tUaW93MlBFSjU5bVh2RHh0WW5TNVF0RHp2a1FWZFpsbjJkN2xIbU16YzRtbTNQRno2YUlySGNOUnpQQVl3YUpBUzVlLW5SQW5taW9xYjh0d2EzVi1Tc3ZwdVdnNGpaOEN2ZVFlMlRKaXN3TWZkVlh2cmJvcDJNLTlqU0Nxdw?oc=5","date":"2012-05-29","type":"pipeline","source":"Asian Scientist Magazine","summary":"Takeda Unveils New Treatment For Hypertension In Japan - Asian Scientist Magazine","headline":"Takeda Unveils New Treatment For Hypertension In Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPbXZiQWY4WFgtNVdIUE9Ndy1YOWVjYll0bzlJMF9vVm1jYURVbkxEcmRNejFvT1NkOV94bEhQQjdDNG5hbzBNaWdTZ2p4ZVliV2JoOXllbEo3a0JrVW5kQ3pxbWV6YkpxU01Uc0FXNXNEb2Jud2U0N2VKM3FQckFraHd1MHBFOU5QRFE?oc=5","date":"2012-05-28","type":"deal","source":"Asian Scientist Magazine","summary":"Takeda To Acquire Brazil’s Multilab For US$250 Million - Asian Scientist Magazine","headline":"Takeda To Acquire Brazil’s Multilab For US$250 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQQnkyZGRJQVNxZ1BGX05SMzRIc3ZwbGRrODltYXhHNEZhMzFJM1NhTUlPbU1pdF95cVpmdERfTHl0VU1JNERpLTJuZVNNU1hYSjlUYzBDTHBNYV94cHlaN1BFX3EzeURmczNMTFY1ZGxac3FsRXhwb3lBWnAzOFFlclVfRzQ4V3laTVg3NmxvTTJyYTFJbjJZ?oc=5","date":"2011-08-06","type":"trial","source":"Asian Scientist Magazine","summary":"Amylin and Takeda Discontinue Phase II Obesity Drug Combination Therapy - Asian Scientist Magazine","headline":"Amylin and Takeda Discontinue Phase II Obesity Drug Combination Therapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}